These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 6125670

  • 21. Removal of aluminium from patients with dialysis encephalopathy.
    Adhemar JP, Laederich J, Jaudon MC, Masselot JP, Galli A, Kleinknecht D.
    Lancet; 1980 Dec 13; 2(8207):1311. PubMed ID: 6108489
    [No Abstract] [Full Text] [Related]

  • 22. Treatment of early stages of dialysis encephalopathy by aluminium depletion.
    Pogglitsch H, Petek W, Wawschinek O, Holzer W.
    Lancet; 1981 Dec 12; 2(8259):1344-5. PubMed ID: 6118738
    [No Abstract] [Full Text] [Related]

  • 23. Composition of the domestic water supply and the incidence of fractures and encephalopathy in patients on home dialysis.
    Platts MM, Goode GC, Hislop JS.
    Br Med J; 1977 Sep 10; 2(6088):657-60. PubMed ID: 902042
    [Abstract] [Full Text] [Related]

  • 24. Brain-aluminium concentration in dialysis encephalopathy.
    McDermott JR, Smith AI, Ward MK, Parkinson IS, Kerr DN.
    Lancet; 1978 Apr 29; 1(8070):901-4. PubMed ID: 76845
    [Abstract] [Full Text] [Related]

  • 25. International Workshop on the role of biological monitoring in the prevention of aluminium toxicity in man: "Aluminium Analysis in Biological Fluids," Luxembourg, July 5-7, 1982. Memorandum on the summary and conclusions.
    J Toxicol Clin Toxicol; 1982 Oct 29; 19(8):907-10. PubMed ID: 7182518
    [No Abstract] [Full Text] [Related]

  • 26. Aluminium toxicity during regular haemodialysis.
    Elliott HL, Dryburgh F, Fell GS, Sabet S, Macdougall AI.
    Br Med J; 1978 Apr 29; 1(6120):1101-3. PubMed ID: 638617
    [Abstract] [Full Text] [Related]

  • 27. Water supply aluminium concentration, dialysis dementia, and effect of reverse-osmosis water treatment.
    Davison AM, Walker GS, Oli H, Lewins AM.
    Lancet; 1982 Oct 09; 2(8302):785-7. PubMed ID: 6126664
    [Abstract] [Full Text] [Related]

  • 28. Therapy of aluminium overload (II).
    Ackrill P, Day JP.
    Contrib Nephrol; 1984 Oct 09; 38():78-80. PubMed ID: 6713902
    [No Abstract] [Full Text] [Related]

  • 29. Cerebrospinal fluid aluminum levels following deferoxamine.
    Ellenberg R, King AL, Sica DA, Posner M, Savory J.
    Am J Kidney Dis; 1990 Aug 09; 16(2):157-9. PubMed ID: 2382654
    [Abstract] [Full Text] [Related]

  • 30. The efficacy of various treatment modalities on aluminium associated bone disease.
    Ihle BU, Buchanan MR, Stevens B, Becker GJ, Kincaid-Smith P.
    Proc Eur Dial Transplant Assoc; 1983 Aug 09; 19():195-202. PubMed ID: 6348735
    [Abstract] [Full Text] [Related]

  • 31. Cela n'arrive qu'aux autres (aluminium intoxication only happens in the other nephrologist's dialysis centre).
    Simoes J, Barata JD, D'Haese PC, De Broe ME.
    Nephrol Dial Transplant; 1994 Aug 09; 9(1):67-8. PubMed ID: 8177479
    [No Abstract] [Full Text] [Related]

  • 32. Aluminium-related bone disease and haemodialysis.
    Seyfert UT, Didion K, Albert FW.
    Lancet; 1987 Aug 22; 2(8556):456. PubMed ID: 2887758
    [No Abstract] [Full Text] [Related]

  • 33. Measurement of aluminium in dialysis fluid and water by a spectrophotometric procedure.
    Sampson B, Fleck A.
    Analyst; 1984 Mar 22; 109(3):369-72. PubMed ID: 6721163
    [No Abstract] [Full Text] [Related]

  • 34. Treatment of dialysis osteomalacia with desferrioxamine.
    Brown DJ, Dawborn JK, Ham KN, Xipell JM.
    Lancet; 1982 Aug 14; 2(8294):343-5. PubMed ID: 6124756
    [Abstract] [Full Text] [Related]

  • 35. Clinical experience with desferrioxamine in dialysis patients with aluminium toxicity.
    McCarthy JT, Milliner DS, Johnson WJ.
    Q J Med; 1990 Mar 14; 74(275):257-76. PubMed ID: 2117295
    [Abstract] [Full Text] [Related]

  • 36. Is aluminium a dementing ion?
    Lancet; 1992 Mar 21; 339(8795):713-4. PubMed ID: 1347589
    [No Abstract] [Full Text] [Related]

  • 37. Recent developments in aluminum toxicology.
    Monteagudo FS, Cassidy MJ, Folb PI.
    Med Toxicol Adverse Drug Exp; 1989 Mar 21; 4(1):1-16. PubMed ID: 2651849
    [Abstract] [Full Text] [Related]

  • 38. Successful treatment of aluminium encephalopathy by intraperitoneal desferrioxamine.
    Payton CD, Junor BJ, Fell GS.
    Lancet; 1984 May 19; 1(8386):1132-3. PubMed ID: 6144870
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.